Johnson & Johnson (XSWX:JNJ) 6-Month Price Index: 1.16 (As of Aug. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:JNJ Johnson & Johnson XSWX:JNJ
83 GF Score
Price CHF218.70
GF Value CHF154.26
! 7 Warning Signs
View Full Analysis

What is Johnson & Johnson 6-Month Price Index?

Johnson & Johnson XSWX:JNJ +0.21% 83 6-Month Price Index is 1.16 as of Aug. 26, 2026. GuruFocus rates XSWX:JNJ with a GF Score™ of 83/100 and a GF Value™ of CHF154.26. The stock has 7 warning signs investors should review.

6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. It’s calculated by current share price divided by share price 6-months ago. As of today (2026-08-26), Johnson & Johnson's 6-Month Price Index is 1.16.

Johnson & Johnson  (XSWX:JNJ) 6-Month Price Index Explanation

Price Index (PI) also called momentum. Strategies involving Price Index are also known as momentum strategies as they allow investors to profit from a company’s stock price. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago.

The investment strategy for momentum investors is to buy winners and sell losers. That is, buy stocks that performed well and sell stocks that performed poorly in the past.

Johnson & Johnson 6-Month Price Index Related Terms

XSWX:JNJ vs ABBV, MRK, LLY: 6-Month Price Index Comparison

For the Drug Manufacturers - General subindustry, Johnson & Johnson's 6-Month Price Index, along with its competitors' market caps and 6-Month Price Index data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

XSWX:JNJ
83GF Score
Johnson & Johnson XSWX:JNJ
6-Month Price Index is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Johnson & Johnson  (XSWX:JNJ) 6-Month Price Index Calculation

6-Month Price Index is calculated as following:

6-Month Price Index=Current Share Price / Share Price 6-Months Ago

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 6-Month Price Index →
What does a 6-Month Price Index of 1.16 mean?
Johnson & Johnson (XSWX:JNJ) has a 6-Month Price Index of 1.16 as of Aug. 26, 2026. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Johnson & Johnson and its competitors.
Is Johnson & Johnson's 6-Month Price Index too high?
Johnson & Johnson's current 6-Month Price Index is 1.16. Overall, Johnson & Johnson has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Johnson & Johnson's 6-Month Price Index compare to ABBV and MRK?
Johnson & Johnson's 6-Month Price Index of 1.16 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-Month Price Index for a Drug Manufacturers company?
A good 6-Month Price Index depends on the Drug Manufacturers industry context. However, 6-Month Price Index should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-Month Price Index mean?
A high 6-Month Price Index can signal that a stock is expensive relative to its fundamentals. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Johnson & Johnson and its competitors. Johnson & Johnson's current 6-Month Price Index is 1.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson & Johnson stock overvalued right now?
Johnson & Johnson (XSWX:JNJ) has a current 6-Month Price Index of 1.16. The stock's GF Value™ is CHF154.26, compared to a current price of CHF218.70 — trading 41.8% above its estimated fair value. The current 6-Month Price Index is 1.16. Johnson & Johnson's overall GF Score™ is 83/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-Month Price Index calculated?
6-Month Price Index is calculated from a company's financial statements. For Johnson & Johnson (XSWX:JNJ), the current 6-Month Price Index is 1.16 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Johnson & Johnson (XSWX:JNJ) Overvalued in 2026?

Based on GuruFocus' analysis, Johnson & Johnson stock appears to be overvalued. The current stock price of CHF218.70 is trading 41.8% above its estimated GF Value™ of CHF154.26.

Key valuation signals for XSWX:JNJ:

  • 6-Month Price Index: 1.16
  • GF Value™: CHF154.26 vs. price of CHF218.70 (41.8% above fair value)
  • GF Score™: 83/100 with 7 warning signs

No single metric tells the full story. See the XSWX:JNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Johnson & Johnson Business Description

Address One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
83GF Score

Get the complete analysis for XSWX:JNJ

6-Month Price Index is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF218.70
Price
CHF154.26
GF Value